Celldex
Manufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Perryville Iii Building suite 220 53 Fro...Phone Number
(908) 454-7120Website
www.celldex.comRevenue
<$5 MillionStock Symbol
CLDXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Celldex
Founded in 1983, Celldex Therapeutics is a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care. They are based in Hampton, New Jersey.Explore more
Celldex Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Celldex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Celldex, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Celldex launches new products
Check out if Celldex is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Celldex
Earning: See what the market has to say on Celldex recently announced quarterly report
Click to see if Celldex had a recent Job posting/layoffs
Check if Celldex has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Celldex has new funding data
Recommended Actions
Reach out to Masked Content who joined Celldex as Masked Content
Find more new buyers
Compare Similar Companies to Celldex
Compare insights from companies similar to Celldex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$114.2M
51-200
Public
$462.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
Company Profile Activity
Activity Insights
Celldex is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Celldex is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Celldex.
Celldex Tech Stack
A closer look at the technologies used by Celldex
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
Hiring Plans
Celldex News & Media
Celldex Therapeutics Spotlights Barzolvolimab as Phase III CSU Data Looms After Fast Enrollment
Celldex Therapeutics (NASDAQ:CLDX) executives used an appearance at H.C. Wainwright’s annual Inflammation and Skin Disease Conference to highlight the company’s late-stage plans for barzolvolimab, an anti-KIT monoclonal antibody being developed for chronic urticaria and other inflammatory skin diseaCelldex to Present at Upcoming Investor Conference
HAMPTON, N.J., April 13, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in a fireside chat at H.C. Wainwright’s 4th Annual Inflammatory Skin Disease Virtual Conference on Tuesday, April 14 at 3:30 pm ET.Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
HAMPTON, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the closing of its previously announced underwritten public offering of 11,896,750 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase an additional 1,551,750 shares of common stock at a public offering price of $29.00 per share. All of the shares sold in the offering were soldCelldex Announces Pricing of $300 Million Public Offering of Common Stock
HAMPTON, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an underwritten public offering of 10,345,000 shares of its common stock at a public offering price of $29.00 per share. All of the shares to be sold in the offering are to be sold by Celldex. In connection with the offering, Celldex has also granted the underwriters a 30-day option to purchase up
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Celldex
Sign Up For FreeTo access detailed company insights
Founded in 1983, Celldex Therapeutics is a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care. They are based in Hampton, New Jersey.... Read More
